Qiagen (QGEN) Expected to Announce Quarterly Earnings on Wednesday

Qiagen (NYSE:QGEN) is expected to be issuing its quarterly earnings data after the market closes on Wednesday, February 5th. Analysts expect the company to announce earnings of $0.60 per share and revenue of $518.54 million for the quarter. Parties that are interested in registering for the company’s conference call can do so using this link.

Qiagen Price Performance

NYSE QGEN opened at $43.85 on Tuesday. The firm’s fifty day simple moving average is $43.75 and its two-hundred day simple moving average is $43.23. The company has a current ratio of 2.17, a quick ratio of 1.89 and a debt-to-equity ratio of 0.39. Qiagen has a 12-month low of $40.15 and a 12-month high of $49.30. The firm has a market capitalization of $9.73 billion, a P/E ratio of 109.31, a P/E/G ratio of 3.10 and a beta of 0.37.

Analyst Ratings Changes

QGEN has been the topic of several analyst reports. HSBC lowered shares of Qiagen from a “buy” rating to a “hold” rating and set a $47.64 price target on the stock. in a report on Thursday, October 17th. Morgan Stanley reiterated an “equal weight” rating and set a $46.67 price objective (down from $48.61) on shares of Qiagen in a research note on Monday, January 6th. Jefferies Financial Group reiterated a “buy” rating and set a $52.50 price objective (up from $40.83) on shares of Qiagen in a research note on Tuesday, December 10th. Finally, Hsbc Global Res upgraded shares of Qiagen to a “hold” rating in a research note on Thursday, October 17th. Four investment analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $50.07.

Qiagen Company Profile

QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials.